Psychosocial Adjunctive Treatment for Hypersomnia (PATH)

Completed · Not applicable

Conditions studied: Narcolepsy, Idiopathic Hypersomnia

In brief

Current pharmacological treatments for chronic hypersomnia (narcolepsy, idiopathic hypersomnia) can effectively reduce excessive daytime sleepiness but a high proportion of patients experience depressive symptoms and poor health-related quality of life. Unfortunately, there are currently no psychosocial interventions that directly addresses this issue. Therefore, the overall goal of this project is to gather initial outcome data and work out methodological issues to determine if a future pragmatic clinical trial is warranted.

Key facts

Study ID

NCT03904238

Run by

Northwestern University

People needed

35

Starts

2018-12-10

Expected to finish

2019-10-07

Last updated by the study team

2019-11-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females age 18 and older.
• Meets criteria for Narcolepsy (Type I or II) or Idiopathic Hypersomnia (IH).
• Moderate to severe symptoms of depression.
• Established standard care for CH at a sleep clinic.

You may not qualify if…

• Hypersomnia not of central origin.
• Current suicidal ideation or intent.
• Uncontrolled medical conditions or physical limitations that require immediate medical treatment that would prevent ability to engage in the treatment protocol.
• Inability to engage in the treatment protocol due to a psychiatric or cognitive issue.
• Untreated moderate-to-severe sleep-related breathing disorder.
• Unable to attend intervention sessions due to accessibility or availability.

Where it is running

• Center for Circadian and Sleep Medicine, Northwestern University — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.